Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
Related posts
-
Column: White Sox are making the Cubs look great by self-destructing in the City Series
The City Series has been a snooze so far, with two relatively easy wins for the... -
Lawmakers seek to reverse Illinois law penalizing companies that boycott Israel
A growing number of state lawmakers are moving to repeal a 2015 Illinois law penalizing companies... -
Kids enjoy hands-on exhibits at first responders expo
Children and their families got an up-close look at dozens of police and fire equipment from...